Fourpath Capital Management
CME icon

Fourpath Capital Management’s CME Group CME Stock Holding History

Fourpath Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.1M Sell
19,482
-96
-0.5% -$25.3K 0.66% 36
2026
Q2 		$4.32M Buy
19,578
+413
+2% +$114K 0.57% 46
2026
Q1 		$5.66M Buy
19,165
+1,202
+7% +$357K 0.81% 30
2025
Q4 		$4.91M Buy
17,963
+2,366
+15% +$643K 0.67% 37
2025
Q3 		$4.21M Sell
15,597
-75
-0.5% -$20.4K 0.6% 46
2025
Q2 		$4.32M Sell
15,672
-196
-1% -$53.3K 0.68% 39
2025
Q1 		$4.21M Sell
15,868
-75
-0.5% -$18.5K 0.73% 39
2024
Q4 		$3.7M Sell
15,943
-453
-3% -$104K 0.69% 44
2024
Q3 		$3.62M Buy
+16,396
New +$3.39M 0.67% 46

Other funds holding CME

PineStone Asset Management
PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Carnegie Investment Counsel
Carnegie Investment Counsel Pepper Pike, Ohio $5.01B AUM 15.78% 1-Year Est. Return

Fourpath Capital Management's CME Position: Q3 2026 in Review

Fourpath Capital Management reduced its CME Group (CME) stake by 0.49% in Q3 2026, selling an estimated $25.3K and leaving 19,482 shares worth $5.1M. The position accounts for 0.66% of the portfolio, ranked #36.

Fourpath Capital Management first reported a position in CME in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.66M in Q1 2026. 301 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Fourpath Capital Management held 19,482 shares of CME Group worth $5.1M as of Q3 2026.
  • Fourpath Capital Management sold 96 CME Group shares in Q3 2026, an estimated $25.3K.
  • CME Group made up 0.66% of Fourpath Capital Management's portfolio in Q3 2026, its #36 holding.
  • Fourpath Capital Management first reported a position in CME Group in Q3 2024 and has held it in 9 quarters since.
  • Fourpath Capital Management's CME Group position peaked at $5.66M in Q1 2026.
  • 301 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.